ArticleJournal of clinical microbiology2017

Performance of Vitek 2 for Antimicrobial Susceptibility Testing of Acinetobacter baumannii, Pseudomonas aeruginosa, and Stenotrophomonas maltophilia with Vitek 2 (2009 FDA) and CLSI M100S 26th Edition Breakpoints.

April M Bobenchik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.